Lundbeck Inc.

Lundbeck Inc.

Lundbeck Inc. serves as the single-family office for the family behind Lundbeck A/S, a global pharmaceutical company founded in Denmark in 1915 by Jørgen Lundbeck. The firm is headquartered in Deerfield, Illinois, United States, reflecting the family's North American operations. No founding year for the family office itself has been publicly disclosed. The family office's investment strategy centers on healthcare, with a particular emphasis on pharmaceuticals. The underlying capital derives from the Lundbeck family's stake in Lundbeck A/S, a publicly traded neuroscience-focused drugmaker that generated DKK 17.6 billion (approximately USD 2.5 billion) in revenue in 2024. No detailed allocation across asset classes or specific portfolio companies has been made public. Lundbeck Inc. operates with a lean team. The firm does not disclose the number of professionals. No recent operational events have been publicly reported. The Lundbeck family also maintains the Lundbeck Foundation, a charitable entity based in Denmark that supports neuroscience research and holds a controlling interest in Lundbeck A/S. The family office's primary structural differentiator is its tight connection to the founding family's pharmaceutical company. The office likely manages concentrated wealth tied to the Lundbeck A/S controlling share, a long-term hold that shapes its investment horizon and risk tolerance.